Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $77.62 USD
Change Today +3.18 / 4.27%
Volume 1.1M
CRL On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - charles river laboratories (CRL)

Name (Connections)Board RelationshipsTitleKey Developments
George Massaro 93 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Executive Committee 
Robert Bertolini 63 RelationshipsIndependent Director, Chairman of Strategic Planning & Capital Allocation Committee, Member of Executive Committee and Member of Audit Committee 
Stephen Chubb 14 RelationshipsIndependent Director, Member of Audit Committee and Member of Science & Technology Committee 

Compensation Committee* - charles river laboratories (CRL)

Name (Connections)Board RelationshipsTitle
Deborah Kochevar DVM, Ph.D., DACVCP 8 RelationshipsIndependent Director, Member of Corporate Governance & Nominating Committee, Member of Compensation Committee and Member of Science & Technology Committee
C. Reese 16 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
Richard Wallman 57 RelationshipsIndependent Director, Member of Strategic Planning & Capital Allocation Committee and Member of Compensation Committee
CRL Compensation vs. Industry
1.1M
417.0K
Chief Executive Officer
530.3K
313.5K
Chief Financial Officer
Share price activity for CHARLES RIVER LABORATORIES (CRL)
52 Week Price Performance
CRL
Industry Average

Nominating Committee* - charles river laboratories (CRL)

Name (Connections)Board RelationshipsTitleKey Developments
George Milne Jr., Ph.D., MBA 72 RelationshipsLead Director, Chairman of Corporate Governance & Nominating Committee, Member of Executive Committee and Member of Science & Technology CommitteeThomas F. Ackerman to Retire as Corporate Executive Vice President and Chief Financial Officer of Charles River Laboratories International, Inc. in February 2016
02/24/15
Craig Thompson M.D. 140 RelationshipsIndependent Director, Chairman of Science & Technology Committee and Member of Corporate Governance & Nominating CommitteeCharles River Laboratories International Announces Management Changes
11/3/14
Deborah Kochevar DVM, Ph.D., DACVCP 8 RelationshipsIndependent Director, Member of Corporate Governance & Nominating Committee, Member of Compensation Committee and Member of Science & Technology CommitteeCharles River Laboratories International, Inc. Announces Board Changes
12/9/13

Corporate Governance Committee* - charles river laboratories (CRL)

Name (Connections)Board RelationshipsTitle
Deborah Kochevar DVM, Ph.D., DACVCP 8 RelationshipsIndependent Director, Member of Corporate Governance & Nominating Committee, Member of Compensation Committee and Member of Science & Technology Committee
George Milne Jr., Ph.D., MBA 72 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
Craig Thompson M.D. 140 RelationshipsIndependent Director, Member of Strategic Planning & Capital Allocation Committee and Member of Compensation Committee
CRL and Competitor
Insiders vs. External
Board
11%
89%
Charles River Laboratories International, Inc.
50%
50%
Bioanalytical Systems Inc.
29%
71%
PAREXEL International Corporation
29%
71%
WuXi PharmaTech (Cayman) Inc.
17%
83%
Quintiles Transnational Holdings Inc.
50%
50%
Ergomed Plc
Insiders
External Board Members

Executive Committee* - charles river laboratories (CRL)

Name (Connections)Board RelationshipsTitle
Robert Bertolini 63 RelationshipsIndependent Director, Chairman of Strategic Planning & Capital Allocation Committee, Member of Executive Committee and Member of Audit Committee
James Foster J.D. 53 RelationshipsChairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
George Massaro 93 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Executive Committee
George Milne Jr., Ph.D., MBA 72 RelationshipsLead Director, Chairman of Corporate Governance & Nominating Committee, Member of Executive Committee and Member of Science & Technology Committee
C. Reese 16 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
William Waltrip 14 RelationshipsFormer Lead Independent Director, Chairman of Compensation Committee, Member of Executive Committee and Member of Corporate Governance & Nominating Committee
Management Effectiveness Relative to the Industry
Return on Equity
1.8x
Return on Assets
1.2x
Return on Total Capital
1.1x
TEV/Total Revenue(LTM)
1.1x
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRL:US $77.62 USD +3.18

CRL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bioanalytical Systems Inc $1.47 USD 0.00
Ergomed PLC 180.00 GBp 0.00
PAREXEL International Corp $68.96 USD +0.28
Quintiles Transnational Holdings Inc $76.72 USD -2.03
WuXi PharmaTech Cayman Inc $41.50 USD 0.00
View Industry Companies
 

Industry Analysis

CRL

Industry Average

Valuation CRL Industry Range
Price/Earnings 26.3x
Price/Sales 2.8x
Price/Book 5.2x
Price/Cash Flow 22.0x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHARLES RIVER LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.